News

What is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...
When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...
Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...
A STEMI heart attack is the most serious kind because one of the heart’s main supply arteries is completely blocked. After ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
The recent surge in sudden deaths and collapses has sparked widespread concern, with many questioning the underlying causes. Reports of individuals collapsing without warning have become increasingly ...
BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...
Mount Nittany Health Emergency Medical Services has been honored with the American Heart Association’s 2025 Mission: Lifeline ...
In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
Researchers from The University of Western Australia, working with medtech industry partners Artrya, have developed a new, ...
For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...